Skip to main content
main-content
Erschienen in: Endocrine 2/2020

16.05.2020 | Original Article

Post-transplant diabetes mellitus: incidence, predicting factors and outcomes

verfasst von: Nadav Mizrahi, Marius Braun, Tuvia Ben Gal, Dror Rosengarten, Mordechai Reuven Kramer, Alon Grossman

Erschienen in: Endocrine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify predictors and evaluate outcomes of posttransplant diabetes mellitus (PTDM) and to investigate the effect of treatment modalities on outcomes.

Methods

The database of a tertiary medical center was searched for all adult patients without prior diabetes who underwent lung, liver, or heart transplantation between January 1, 2012 and June 30, 2018. Patients in whom PTDM (defined as HbA1C ≥ 6.5% at least 3 months post transplantation) developed during follow-up (mean 3.32 years) were identified. Risk factors for PTDM, determined by regression analysis and clinical outcomes [all-cause mortality, severe infections, graft loss, and major adverse cardiovascular events (MACE)], were compared between those who developed PTDM and those who did not; in the former, insulin-based therapy was compared with non-insulin regimen.

Results

The cohort included 281 transplant recipients: 158 lung, 109 liver, and 14 heart. PTDM was diagnosed in 60 (21.35%) patients at a mean of 11.3 ± 12.89 months post transplantation. The only significant independent risk factor for PTDM was age (HR 1.028, 95% CI = 1.002–1.054, P = 0.0314). PTDM was associated with higher rates of severe infections (HR 2.565, 95% CI = 1.626–4.050, P < 0.0001), MACE (HR 1.856, 95% CI = 1.013–3.401, P = 0.0454) and death (HR 1.840, 95% CI = 1.024–3.304, P = 0.0413). Recipients treated with insulin-based regimens had a higher risk of severe infections (HR 2.579, 95% CI = 1.640–4.055, P < 0.0001), MACE (1.925, 95% CI = 1.074–3.451, P = 0.0278) and death (HR 1.960, 95% CI = 1.071–3.586, P = 0.0291).

Conclusions

PTDM is associated with increased mortality and poor outcomes in lung, liver, and heart transplant recipients. Early identification and aggressive treatment of PTDM and its associated cardiometabolic risk factors may improve outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Q. Ling, X. Xu, H. Xie, K. Wang, P. Xiang, R. Zhuang, T. Shen, J. Wu, W. Wang, S. Zheng, New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry. Liver Int. 36, 705–712 (2016) CrossRef Q. Ling, X. Xu, H. Xie, K. Wang, P. Xiang, R. Zhuang, T. Shen, J. Wu, W. Wang, S. Zheng, New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry. Liver Int. 36, 705–712 (2016) CrossRef
2.
Zurück zum Zitat V. Bhat, M. Tazari, K.D. Watt, M. Bhat, New-onset diabetes and preexisting diabetes are associated with comparable reduction in long-term survival after liver transplant: a machine learning approach. Mayo Clin. Proc. 93, 1794–1802 (2018) CrossRef V. Bhat, M. Tazari, K.D. Watt, M. Bhat, New-onset diabetes and preexisting diabetes are associated with comparable reduction in long-term survival after liver transplant: a machine learning approach. Mayo Clin. Proc. 93, 1794–1802 (2018) CrossRef
3.
Zurück zum Zitat C. Lv, Y. Zhang, X. Chen, X. Huang, M. Xue, Q. Sun, T. Wang, J. Liang, S. He, J. Gao, J. Zhou, M. Yu, J. Fan, X. Gao, New-onset diabetes after liver transplantation and its impact on complications and patient survival. J. Diabetes 7, 881–890 (2015) CrossRef C. Lv, Y. Zhang, X. Chen, X. Huang, M. Xue, Q. Sun, T. Wang, J. Liang, S. He, J. Gao, J. Zhou, M. Yu, J. Fan, X. Gao, New-onset diabetes after liver transplantation and its impact on complications and patient survival. J. Diabetes 7, 881–890 (2015) CrossRef
4.
Zurück zum Zitat H.T. Kuo, M.S. Sampaio, X. Ye, P. Reddy, P. Martin, S. Bunnapradist, Risk factors for newonset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 89, 1134–1140 (2010) CrossRef H.T. Kuo, M.S. Sampaio, X. Ye, P. Reddy, P. Martin, S. Bunnapradist, Risk factors for newonset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 89, 1134–1140 (2010) CrossRef
5.
Zurück zum Zitat A.D. Yadav, Y.H. Chang, B.A. Aqel, T.J. Byrne, H.A. Chakkera, D.D. Douglas, D.C. Mulligan, J. Rakela, H.E. Vargas, E.J. Carey, New onset diabetes mellitus in living donor versus deceased donor liver transplant recipients: analysis of the UNOS/OPTN database. J. Transplant. 2013, 269096 (2013) CrossRef A.D. Yadav, Y.H. Chang, B.A. Aqel, T.J. Byrne, H.A. Chakkera, D.D. Douglas, D.C. Mulligan, J. Rakela, H.E. Vargas, E.J. Carey, New onset diabetes mellitus in living donor versus deceased donor liver transplant recipients: analysis of the UNOS/OPTN database. J. Transplant. 2013, 269096 (2013) CrossRef
6.
Zurück zum Zitat M. Zhang, Y. Han, Y. Yuan, J. Cai, J. Zhang, Y. Wang, H. Xiang, H. Zhou, Risk factors for new-onset diabetes mellitus after heart transplantation in Chinese patients: a single center experience. Ann. Nutr. Metab. 74, 331–338 (2019) CrossRef M. Zhang, Y. Han, Y. Yuan, J. Cai, J. Zhang, Y. Wang, H. Xiang, H. Zhou, Risk factors for new-onset diabetes mellitus after heart transplantation in Chinese patients: a single center experience. Ann. Nutr. Metab. 74, 331–338 (2019) CrossRef
7.
Zurück zum Zitat J. Saraiva, E. Sola, D. Prieto, M.J. Antunes, Diabetes as an outcome predictor after heart transplantation. Interact. Cardiovasc. Thorac. Surg. 13, 499–504 (2011) CrossRef J. Saraiva, E. Sola, D. Prieto, M.J. Antunes, Diabetes as an outcome predictor after heart transplantation. Interact. Cardiovasc. Thorac. Surg. 13, 499–504 (2011) CrossRef
8.
Zurück zum Zitat X. Ye, H.T. Kuo, M.S. Sampaio, Y. Jiang, P. Reddy, S. Bunnapradist, Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Transplantation 89, 1526–1532 (2010) CrossRef X. Ye, H.T. Kuo, M.S. Sampaio, Y. Jiang, P. Reddy, S. Bunnapradist, Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Transplantation 89, 1526–1532 (2010) CrossRef
9.
Zurück zum Zitat J.E. Ollech, M.R. Kramer, N. Peled, A. Ollech, A. Amital, B. Medalion, M. Saute, D. Shitrit, Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors. Eur. J. Cardiothorac. Surg. 33, 844–848 (2008) CrossRef J.E. Ollech, M.R. Kramer, N. Peled, A. Ollech, A. Amital, B. Medalion, M. Saute, D. Shitrit, Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors. Eur. J. Cardiothorac. Surg. 33, 844–848 (2008) CrossRef
10.
Zurück zum Zitat K.L. Hackman, G.I. Snell, L.A. Bach, Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study. Diabetes Care. 37, 2919–2925 (2014) CrossRef K.L. Hackman, G.I. Snell, L.A. Bach, Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study. Diabetes Care. 37, 2919–2925 (2014) CrossRef
11.
Zurück zum Zitat N. Saigi-Morgui, L. Quteineh, P.Y. Bochud, S. Crettol, Z. Kutalik, N.J. Mueller, I. Binet, C. Van Delden, J. Steiger, P. Mohacsi, J.F. Dufour, P.M. Soccal, M. Pascual, C.B. Eap, Swiss Transplant Cohort Study: genetic and clinic predictors of new onset diabetes mellitus after transplantation. Pharmacogenomics J. 19, 53–64 (2019) CrossRef N. Saigi-Morgui, L. Quteineh, P.Y. Bochud, S. Crettol, Z. Kutalik, N.J. Mueller, I. Binet, C. Van Delden, J. Steiger, P. Mohacsi, J.F. Dufour, P.M. Soccal, M. Pascual, C.B. Eap, Swiss Transplant Cohort Study: genetic and clinic predictors of new onset diabetes mellitus after transplantation. Pharmacogenomics J. 19, 53–64 (2019) CrossRef
12.
Zurück zum Zitat H.J. Kim, S.H. Jung, J.J. Kim, T.J. Yun, J.B. Kim, S.J. Choo, C.H. Chung, J.W. Lee, New-onset diabetes mellitus after heart transplantation—incidence, risk factors and impact on clinical outcome. Circ. J. 81, 806–814 (2017) CrossRef H.J. Kim, S.H. Jung, J.J. Kim, T.J. Yun, J.B. Kim, S.J. Choo, C.H. Chung, J.W. Lee, New-onset diabetes mellitus after heart transplantation—incidence, risk factors and impact on clinical outcome. Circ. J. 81, 806–814 (2017) CrossRef
13.
Zurück zum Zitat M. Castedal, C. Skoglund, C. Axelson, W. Bennet, Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation. Scand. J. Gastroenterol. 53, 741–747 (2018) CrossRef M. Castedal, C. Skoglund, C. Axelson, W. Bennet, Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation. Scand. J. Gastroenterol. 53, 741–747 (2018) CrossRef
14.
Zurück zum Zitat L. Xie, W. Tang, X. Wang, L. Wang, Y. Lu, T. Lin, Pretransplantation risk factors associated with new-onset diabetes after living-donor kidney transplantation. Transplant. Proc. 48, 3299–3302 (2016) CrossRef L. Xie, W. Tang, X. Wang, L. Wang, Y. Lu, T. Lin, Pretransplantation risk factors associated with new-onset diabetes after living-donor kidney transplantation. Transplant. Proc. 48, 3299–3302 (2016) CrossRef
15.
Zurück zum Zitat M.O. Salifu, F. Tedla, P.V. Murty, S. Aytug, S.I. McFarlane, Challenges in the diagnosis and management of new-onset diabetes after transplantation. Curr. Diab. Rep. 5, 194–199 (2005) CrossRef M.O. Salifu, F. Tedla, P.V. Murty, S. Aytug, S.I. McFarlane, Challenges in the diagnosis and management of new-onset diabetes after transplantation. Curr. Diab. Rep. 5, 194–199 (2005) CrossRef
16.
Zurück zum Zitat F.C. Mazali, C.A. Lalli, G. Alves-Filho, M. Mazzali, Posttransplant diabetes mellitus: incidence and risk factors. Transplant. Proc. 40, 764–766 (2008) CrossRef F.C. Mazali, C.A. Lalli, G. Alves-Filho, M. Mazzali, Posttransplant diabetes mellitus: incidence and risk factors. Transplant. Proc. 40, 764–766 (2008) CrossRef
17.
Zurück zum Zitat S. Palepu, G.V. Prasad, New-onset diabetes mellitus after kidney transplantation: current status and future directions. World J. Diabetes 6, 445–455 (2015) CrossRef S. Palepu, G.V. Prasad, New-onset diabetes mellitus after kidney transplantation: current status and future directions. World J. Diabetes 6, 445–455 (2015) CrossRef
18.
Zurück zum Zitat M.G. Cehic, N. Nundall, J.R. Greenfield, P.S. Macdonald, Management strategies for posttransplant diabetes mellitus after heart transplantation: a review. J. Transplant. 2018, 1025893 (2018) CrossRef M.G. Cehic, N. Nundall, J.R. Greenfield, P.S. Macdonald, Management strategies for posttransplant diabetes mellitus after heart transplantation: a review. J. Transplant. 2018, 1025893 (2018) CrossRef
19.
Zurück zum Zitat M. Hornum, J.P. Lindahl, B. von Zur‐Mühlen, T. Jenssen, B. Feldt‐Rasmussen, Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl. Int. 26, 1049–1060 (2013) CrossRef M. Hornum, J.P. Lindahl, B. von Zur‐Mühlen, T. Jenssen, B. Feldt‐Rasmussen, Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies. Transpl. Int. 26, 1049–1060 (2013) CrossRef
20.
Zurück zum Zitat A.R. Soliman, A. Fathy, S. Khashab, N. Shaheen, M.A. Soliman, Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant. Exp. Clin. Transplant. 11, 494–498 (2013) CrossRef A.R. Soliman, A. Fathy, S. Khashab, N. Shaheen, M.A. Soliman, Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant. Exp. Clin. Transplant. 11, 494–498 (2013) CrossRef
21.
Zurück zum Zitat M. Haidinger, J. Werzowa, M. Hecking, M. Antlanger, G. Stemer, J. Pleiner, C. Kopecky, J.J. Kovarik, D. Döller, G. Pacini, M.D. Säemann, Efficacy and safety of vildagliptin in new‐onset diabetes after kidney transplantation-a randomized, double‐blind, placebo‐controlled trial. Am. J. Transpl. 14, 115–123 (2014) CrossRef M. Haidinger, J. Werzowa, M. Hecking, M. Antlanger, G. Stemer, J. Pleiner, C. Kopecky, J.J. Kovarik, D. Döller, G. Pacini, M.D. Säemann, Efficacy and safety of vildagliptin in new‐onset diabetes after kidney transplantation-a randomized, double‐blind, placebo‐controlled trial. Am. J. Transpl. 14, 115–123 (2014) CrossRef
22.
Zurück zum Zitat A. Sharif, M. Hecking, A.P. de Vries, E. Porrini, M. Hornum, S. Rasoul-Rockenschaub, G. Berlakovich, M. Krebs, A. Kautzky-Willer, G. Schernthaner, P. Marchetti, G. Pacini, A. Ojo, S. Takahara, J.L. Larsen, K. Budde, K. Eller, J. Pascual, A. Jardine, S.J. Bakker, T.G. Valderhaug, T.G. Jenssen, S. Cohney, M.D. Säemann, Proceedings from an International Consensus Meeting on Posttransplantation Diabetes Mellitus: recommendations and future directions. Am. J. Transplant. 14, 1992–2000 (2014) CrossRef A. Sharif, M. Hecking, A.P. de Vries, E. Porrini, M. Hornum, S. Rasoul-Rockenschaub, G. Berlakovich, M. Krebs, A. Kautzky-Willer, G. Schernthaner, P. Marchetti, G. Pacini, A. Ojo, S. Takahara, J.L. Larsen, K. Budde, K. Eller, J. Pascual, A. Jardine, S.J. Bakker, T.G. Valderhaug, T.G. Jenssen, S. Cohney, M.D. Säemann, Proceedings from an International Consensus Meeting on Posttransplantation Diabetes Mellitus: recommendations and future directions. Am. J. Transplant. 14, 1992–2000 (2014) CrossRef
23.
Zurück zum Zitat L. Cooper, N. Oz, G. Fishman, T. Shohat, R. Rahamimov, E. Mor, H. Green, A. Grossman, New onset diabetes after kidney transplantation is associated with increased mortality—a retrospective cohort study. Diabetes Metab. Res. Rev. 33, e2920 (2017) CrossRef L. Cooper, N. Oz, G. Fishman, T. Shohat, R. Rahamimov, E. Mor, H. Green, A. Grossman, New onset diabetes after kidney transplantation is associated with increased mortality—a retrospective cohort study. Diabetes Metab. Res. Rev. 33, e2920 (2017) CrossRef
24.
Zurück zum Zitat S. Kesiraju, P. Paritala, Ch,U.M. Rao, S. Sahariah, New onset of diabetes after transplantationd an overview of epidemiology, mechanism of development and diagnosis. Transpl. Immunol. 30, 52–58 (2014) CrossRef S. Kesiraju, P. Paritala, Ch,U.M. Rao, S. Sahariah, New onset of diabetes after transplantationd an overview of epidemiology, mechanism of development and diagnosis. Transpl. Immunol. 30, 52–58 (2014) CrossRef
25.
Zurück zum Zitat V. Shivaswamy, B. Boerner, J. Larsen, Posttransplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr. Rev. 37, 37–61 (2016) CrossRef V. Shivaswamy, B. Boerner, J. Larsen, Posttransplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr. Rev. 37, 37–61 (2016) CrossRef
26.
Zurück zum Zitat R.J. Galindo, A. Wallia, Hyperglycemia and diabetes mellitus following organ transplantation. Curr. Diab. Rep. 16, 14 (2016) CrossRef R.J. Galindo, A. Wallia, Hyperglycemia and diabetes mellitus following organ transplantation. Curr. Diab. Rep. 16, 14 (2016) CrossRef
27.
Zurück zum Zitat R.D. Yusen, J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya, C. Benden, A.I. Dipchand, F. Dobbels, R. Kirk, L.H. Lund, A.O. Rahmel, J. Stehlik, The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report–2013; focus theme: age. Am. J. Transplant. 32(10), 965–78 (2013) R.D. Yusen, J.D. Christie, L.B. Edwards, A.Y. Kucheryavaya, C. Benden, A.I. Dipchand, F. Dobbels, R. Kirk, L.H. Lund, A.O. Rahmel, J. Stehlik, The registry of the international society for heart and lung transplantation: thirtieth adult lung and heart-lung transplant report–2013; focus theme: age. Am. J. Transplant. 32(10), 965–78 (2013)
28.
Zurück zum Zitat S. Baid, A. B. Cosimi, M. L. Farrell, D. A. Schoenfeld, S. Feng, R. T. Chung, N. Tolkoff-Rubin, M. Pascual, Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 72, 1066–1072 (2001) CrossRef S. Baid, A. B. Cosimi, M. L. Farrell, D. A. Schoenfeld, S. Feng, R. T. Chung, N. Tolkoff-Rubin, M. Pascual, Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 72, 1066–1072 (2001) CrossRef
29.
Zurück zum Zitat K.A. Morbitzer, D.J. Taber, N.A. Pilch, H.B. Meadows, J.N. Fleming, C.F. Bratton, J.W. McGillicuddy, P.K. Baliga, K.D. Chavin, The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin. Transplant. 28, 862–868 (2014) CrossRef K.A. Morbitzer, D.J. Taber, N.A. Pilch, H.B. Meadows, J.N. Fleming, C.F. Bratton, J.W. McGillicuddy, P.K. Baliga, K.D. Chavin, The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin. Transplant. 28, 862–868 (2014) CrossRef
30.
Zurück zum Zitat J.J. Gaynor, G. Ciancio, G. Guerra, J. Sageshima, L. Hanson, D. Roth, M.J. Goldstein, L. Chen, W. Kupin, A. Mattiazzi, L. Tueros, S. Flores, L.J. Barba, A. Lopez, J. Rivas, P. Ruiz, R. Vianna, G.W. Burke 3rd, Single‐centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new‐onset diabetes after transplant. Diabetologia 58, 334–345 (2015) CrossRef J.J. Gaynor, G. Ciancio, G. Guerra, J. Sageshima, L. Hanson, D. Roth, M.J. Goldstein, L. Chen, W. Kupin, A. Mattiazzi, L. Tueros, S. Flores, L.J. Barba, A. Lopez, J. Rivas, P. Ruiz, R. Vianna, G.W. Burke 3rd, Single‐centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new‐onset diabetes after transplant. Diabetologia 58, 334–345 (2015) CrossRef
31.
Zurück zum Zitat C. Lv, M. Chen, M. Xu, G. Xu, Y. Zhang, S. He, M. Xue, J. Gao, M. Yu, X. Gao, T. Zhu, Influencing factors of new‐onset diabetes after renal transplant and their effect on complications and survival rate. PLoS One 9, e99406 (2014) CrossRef C. Lv, M. Chen, M. Xu, G. Xu, Y. Zhang, S. He, M. Xue, J. Gao, M. Yu, X. Gao, T. Zhu, Influencing factors of new‐onset diabetes after renal transplant and their effect on complications and survival rate. PLoS One 9, e99406 (2014) CrossRef
Metadaten
Titel
Post-transplant diabetes mellitus: incidence, predicting factors and outcomes
verfasst von
Nadav Mizrahi
Marius Braun
Tuvia Ben Gal
Dror Rosengarten
Mordechai Reuven Kramer
Alon Grossman
Publikationsdatum
16.05.2020
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02339-9

Weitere Artikel der Ausgabe 2/2020

Endocrine 2/2020 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.